Search Results
Feb 19, 2026, 11:53 ET SERVICE CORPORATION INTERNATIONAL DECLARES QUARTERLY CASH DIVIDEND
HOUSTON, Texas, Feb. 19, 2026 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today announced that its Board of Directors has approved a quarterly cash
More news about: Service Corporation International
Feb 19, 2026, 03:26 ET Japón aprueba los fortificantes de Prolacta Bioscience, elaborados 100% con leche materna
JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past,
More news about: Prolacta Bioscience
Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past,
More news about: Prolacta Bioscience
Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past,
More news about: Prolacta Bioscience
Feb 19, 2026, 00:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past,
More news about: Prolacta Bioscience
Feb 18, 2026, 14:00 ET Reddy Ice Announces Successful Closing of the Acquisition of Arctic Glacier
Reddy Ice is a portfolio company of SCI Capital Partners LP ("SCI") and a leading manufacturer and distributor of packaged ice in the United States and Mexico."We are pleased to welcome Arctic Glacier into the Reddy Ice and SCI family and excited about the value we can unlock as
More news about: Reddy Ice, LLC
Feb 18, 2026, 09:03 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past,
More news about: Prolacta Bioscience
Feb 17, 2026, 12:54 ET Lenire zeigt durchgängig positive Ergebnisse für Tinnitus-Patienten in den USA in der zweiten Peer-Review-Real-World-Studie
Standorten. Mitteilungen aus der Natur (2024)Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep.US VA Benefits Report Fiscal Year 2024:
More news about: Neuromod Devices
Feb 17, 2026, 07:00 ET Nektar Therapeutics Announces Research Collaboration with UCSF and Dr. Stephen Hauser for NKTR-0165, a Tumor Necrosis Factor Receptor 2 (TNFR2) Antibody, in Multiple Sclerosis
Faustman DL, Davis M, Kuhtreiber WM. TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related Diseases. Int J Mol Sci. 2025 Aug 14;26(16):7839. doi: 10.3390/ijms26167839. PMID: 40869160; PMCID: PMC12386426.
More news about: Nektar Therapeutics
Feb 17, 2026, 05:30 ET Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
controlled pivotal trial. Nature communications (2024)Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep.US VA Benefits Report Fiscal Year 2024:
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
controlled pivotal trial. Nature communications (2024)Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep.US VA Benefits Report Fiscal Year 2024:
More news about: Neuromod Devices
Feb 17, 2026, 05:30 ET Lenire montre des résultats positifs constants pour les patients américains souffrant d'acouphènes dans une deuxième étude en situation réelle évaluée par des pairs.
multi-sites à bras unique. Nature communications (2024)Conlon et al, Sci. Traduire. Med. 12, eabb2830 (2020)Conlon et al, Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep.Rapport sur les prestations de la VA des États-Unis pour
More news about: Neuromod Devices
Feb 16, 2026, 08:28 ET Actor Andreas Szakacs Founds Andreas Szakacs Productions, Announces Himalayan Series Summitfall
performer. His credits include Protocol Horizon, presented by Victoria Hale and directed by Sebastian Laurent with music by Enzo Moretti, and Genesis Code, a sci-fi thriller from Nova Forges directed by Rylan Voss. Both films have been restored and reintroduced to new audiences. The experience of working across
More news about: Andreas Szakacs Productions
Feb 13, 2026, 18:01 ET Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression
Papp, A.; Somlyai, I.; Somlyai, G. Gene Expression Patterns in Lung Adenocarcinoma Cells in Response to Changes in Deuterium Concentration. Int. J. Mol. Sci. 2025, 26, 10969. https://doi.org/10.3390/ijms262210969) has
More news about: HYD LLC
Feb 13, 2026, 02:00 ET EYE PCR erhält CE-Zeichen für fixOflex Endocapsular Device und ermöglicht damit die europäische Markteinführung
Sicherheit und Wirksamkeit einer neuen endokapsulären Vorrichtung für die altersbedingte Kataraktchirurgie: Zwölfmonatige Nachuntersuchung. Transl Vis Sci Technol. 2026;15(2):8,
More news about: EYE PCR
Feb 13, 2026, 02:00 ET EYE PCR Receives CE Mark for fixOflex Endocapsular Device, Enabling European Market Introduction
Pallikaris IG, et al. Safety and efficacy of a new endocapsular device used in age-related cataract surgery: Twelve-month follow-up. Transl Vis Sci Technol. 2026;15(2):8,
More news about: EYE PCR
Feb 13, 2026, 02:00 ET EYE PCR recibe el marcado CE para dispositivo endocapsular fixOflex
y eficacia de un nuevo dispositivo endocapsular utilizado en la cirugía de cataratas relacionada con la edad: Seguimiento de doce meses. Transl Vis Sci Technol. 2026;15(2):8,
More news about: EYE PCR
Feb 13, 2026, 02:00 ET EYE PCR reçoit le marquage CE pour le dispositif endocapsulaire fixOflex, ce qui permet son introduction sur le marché européen.
Pallikaris IG, et al. Safety and efficacy of a new endocapsular device used in age-related cataract surgery : Suivi à douze mois. Transl Vis Sci Technol. 2026;15(2):8,
More news about: EYE PCR
Feb 12, 2026, 08:00 ET U.S. Department of the Air Force Accelerates Cloud Modernization with Oracle
meet their unique operational demands." OCI provides dedicated, secure, and accredited data center support for the DoW, including Top Secret SCI, Special Access Program, and Defense Information Systems Agency Impact Levels 5 and 6 workloads. Oracle National Security Regions are operated by cleared
More news about: Oracle
Feb 12, 2026, 02:41 ET Global Times: Xi visits people in Beijing ahead of Spring Festival, extends greetings to all Chinese
Beijing E-Town, where he viewed displays showcasing sci-tech achievements in fields such as artificial intelligence and robotics, and spoke with researchers and heads of technology enterprises.Xi said he was "even more confident" in the country's sci-tech innovation after seeing what was presented
More news about: Global Times
Feb 11, 2026, 16:15 ET SERVICE CORPORATION INTERNATIONAL ANNOUNCES FOURTH QUARTER 2025 FINANCIAL RESULTS AND PROVIDES 2026 GUIDANCE
HOUSTON, Feb. 11, 2026 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today reported results for the fourth quarter of 2025. Highlights:
More news about: Service Corporation International
Feb 10, 2026, 07:00 ET CooperVision Launches MiSight® 1 day in Japan; Becomes First Myopia Control Contact Lens in Leading Vision Care Market
Padmaja Sankaridurg, Kyoko Ohno-Matsui; IMI 2021 Reports and Digest – Reflections on the Implications for Clinical Practice. Invest. Ophthalmol. Vis. Sci. 2021;62(5):1.
More news about: CooperVision, Inc.
Feb 09, 2026, 09:07 ET Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
crossover clinical trial, Front. Vet. Sci., 19 January 2026.(2) Yael Shilo-Benjamini et al, Therapeutic efficacy and pharmacokinetics of liposomal-cannabidiol injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis, Front. Vet. Sci., 23 August 2023.About
More news about: Innocan Pharma Corporation
Feb 09, 2026, 09:07 ET Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
crossover clinical trial, Front. Vet. Sci., 19 January 2026.(2) Yael Shilo-Benjamini et al, Therapeutic efficacy and pharmacokinetics of liposomal-cannabidiol injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis, Front. Vet. Sci., 23 August 2023.About
More news about: Innocan Pharma Corporation
Feb 05, 2026, 14:30 ET CGE Brings Codenames to New York Toy Fair for the First Time, Showcasing Exciting New Products and Fan-Favorite Hits
will be on an exciting new product line—Codenames: Expansion Packs. The first three themed expansion packs launching this year are Codenames: Sci-Fi Expansion Pack and Codenames: Fairy Tales Expansion Pack for Codenames and Codenames: Duet, and Codenames: Cute Critters Expansion Pack,
More news about: CGE (Czech Games Edition)